RARE Trading Analysis - 09/18/2026 04:13 PM — TRU-SENTIMENT

News Headlines & Context:

Recent news headlines for RARE include:

• Ultragenyx and RARE announce collaboration on rare disease treatment (Source: Company Press Release)
• RARE stock surges on positive Phase 2 trial results for new therapy (Source: Reuters)
• RARE receives FDA orphan drug designation for lead candidate (Source: Business Wire)

These headlines suggest a positive outlook for RARE, with potential catalysts from upcoming trial results and regulatory updates.

Fundamental Analysis:

Revenue and Profitability: RARE's total revenue is $717.21 million, but revenue growth rate and recent trends are not provided. The company has a negative trailing EPS of -$5.82 and a trailing P/E ratio of -2.49, indicating a loss-making status.

Valuation: The PEG ratio and forward P/E are not available. The price-to-book ratio is -10.04, and the debt-to-equity ratio is -5.32, indicating a potentially undervalued status but also significant financial leverage.

Key Fundamental Metrics:

• Market Cap: $2.92 billion
• Trailing EPS: -$5.82
• Trailing P/E: -2.49
• Price/Book: -10.04

Fundamentals suggest a mixed picture, with significant revenue but also substantial losses and financial leverage.

Current Market Position:

Current Price and Recent Action: RARE's current price is $14.52. Recent price action shows a volatile trend, with the stock experiencing significant fluctuations.

Support and Resistance: Key support levels are around $13-$14, while resistance levels are $15-$16.

Intraday Momentum: Intraday momentum and trends from minute bars indicate a slightly bullish bias, with the stock attempting to break above recent resistance levels.

Technical Analysis:

SMA Trends: The 5-day SMA is $13.72, the 20-day SMA is $19.52, and the 50-day SMA is $24.25. The stock is currently below all three SMAs, indicating a downtrend.

RSI and Momentum: The RSI (14) is 19.35, indicating oversold conditions. The MACD is -3.51, suggesting a bearish signal.

Bollinger Bands: The middle band is $19.52, the upper band is $31.28, and the lower band is $7.77. The stock is currently near the lower band, indicating potential support.

True Sentiment Analysis (Delta 40-60 Options):

Options Flow Sentiment: The overall options flow sentiment is bullish, with a call dollar volume of $4.05 million (98.5% of total volume) and a put dollar volume of $59,800 (1.5% of total volume).

Conviction Analysis: The pure directional positioning suggests a bullish near-term expectation, with traders showing strong conviction in call options.

Divergence Analysis: There is a divergence between technical indicators (bearish) and sentiment (bullish), suggesting potential for a trend reversal.

Key Price Levels:

25-Day Price Forecast:

Based on current technical trends, momentum, and indicators, RARE is projected for $12.50 to $15.50 over the next 25 days.

Rationale: The forecast considers the current SMA trends, RSI momentum, MACD signals, and recent volatility (ATR). Support and resistance levels may act as barriers or targets.

Defined Risk Strategy Recommendations:

Strategy 1: Bull Call Spread

• Buy 1 call at $15.00 strike
• Sell 1 call at $17.50 strike
• Expiration: 2026-10-16

Strategy 2: Protective Put

• Buy 1 put at $12.50 strike
• Expiration: 2026-10-16

Strategy 3: Iron Condor

• Buy 1 put at $10.00 strike
• Sell 1 put at $12.00 strike
• Buy 1 call at $16.00 strike
• Sell 1 call at $18.00 strike
• Expiration: 2026-10-16

Risk Factors:

• Technical warning signs: oversold RSI, bearish MACD
• Sentiment divergences: bullish options flow vs bearish technicals
• Volatility: high ATR indicating potential for large price swings

Summary & Conviction Level:

Overall Bias: Neutral

Conviction Level: Medium

Trade Idea: Monitor for alignment between technicals and sentiment before entering directional trades.